-
Novel blood and neuroimaging markers of Alzheimer’s disease and cerebral amyloid angiopathy
https://braincanada.ca/fr/subventions-financées/novel-blood-and-neuroimaging-markers-of-alzheimer-s-disease-and-cerebral-amyloid-angiopathyAs our brains age, they become vulnerable to diseases such as Alzheimer’s disease which can cause dementia. Project Overview As our brains age, they become vulnerable to diseases such as Alzheimer’s disease which can cause dementia. Dementia is defined as cognitive (i.e., thinking) problems that...
-
Novel Cellular and Molecular Mechanisms Regulating Synapse Dysfunction in Alzheimer’s Disease
https://braincanada.ca/fr/subventions-financées/novel-cellular-and-molecular-mechanisms-regulating-synapse-dysfunction-in-alzheimer-s-diseaseIn Alzheimer s disease (AD), critical synaptic connections between neurons disintegrate and cells die. Project Overview In Alzheimer s disease (AD), critical synaptic connections between neurons disintegrate and cells die. The brains of individuals with AD accumulate plaques of a protein fragment...
-
Novel digital and adaptive marker of word-finding difficulties for early detection of Alzheimer’s disease
https://braincanada.ca/fr/subventions-financées/novel-digital-and-adaptive-marker-of-word-finding-difficulties-for-early-detection-of-alzheimer-s-diseaseOver 64% of older adults without neurocognitive disorders report forgetting the names of objects when speaking. Project Overview Over 64% of older adults without neurocognitive disorders report forgetting the names of objects when speaking. These difficulties are commonly dismissed as typical...
-
Novel First-In-Class Melatonin MT2 Receptor Agonist for Neuropathic Pain: Investigational New Drug (IND) – Enabling Studies
https://braincanada.ca/fr/subventions-financées/novel-first-in-class-melatonin-mt2-receptor-agonist-for-neuropathic-pain-investigational-new-drug-ind-enabling-studiesNeuropathic pain is a chronic pain disorder resulting from damage to the nerves. Project Overview Neuropathic pain is a chronic pain disorder resulting from damage to the nerves. It may be due to cancer, diabetes or conditions like fibromyalgia. Neuropathic pain is often eased by antidepressant or...
-
Novel mechanisms regulating intraneuronal Tau clearance as potential targets for Alzheimer’s disease
https://braincanada.ca/fr/subventions-financées/novel-mechanisms-regulating-intraneuronal-tau-clearance-as-potential-targets-for-alzheimer-s-diseaseIn Alzheimer’s disease (AD), the accumulation of toxic Tau protein in neurons leads to the formation of neurofbillary tangles, cell death, and cognitive impairments. Project Overview In Alzheimer’s disease (AD), the accumulation of toxic Tau protein in neurons leads to the formation of...
-
Novel MRI biomarkers for monitoring disease progression in ALS
https://braincanada.ca/fr/subventions-financées/novel-mri-biomarkers-for-monitoring-disease-progression-in-alsFor this project Dr. Sanjay Kalra and his team aims to improve on current techniques to use magnetic resonance imaging (MRI) as a readily available way to examine if a potential new treatment is working to slow down progression of ALS. Project Overview For this project Dr. Sanjay Kalra and his team...
-
Novel Repetitive Transcranial Magnetic Stimulation Paradigm to Reduce Cortical Hyperexcitability in Patients with ALS
https://braincanada.ca/fr/subventions-financées/novel-repetitive-transcranial-magnetic-stimulation-paradigm-to-reduce-cortical-hyperexcitability-in-patients-with-alsALS is a devastating neurological disease characterized by the progressive degeneration of motor neurons leading to paralysis and death. Project Overview ALS is a devastating neurological disease characterized by the progressive degeneration of motor neurons leading to paralysis and death....
-
Novel Retinal Biomarkers for Alzheimer’s Disease
https://braincanada.ca/fr/subventions-financées/novel-retinal-biomarkers-for-alzheimer-s-diseaseIndividuals with Alzheimer’s suffer severe memory loss over time, and eventually are completely dependent on caregivers. Project Overview Individuals with Alzheimer’s suffer severe memory loss over time, and eventually are completely dependent on caregivers. Age is a significant risk factor, and...
-
Novel therapeutic strategies to repair brain abnormalities in psychiatric disorders
https://braincanada.ca/fr/subventions-financées/novel-therapeutic-strategies-to-repair-brain-abnormalities-in-psychiatric-disordersCommunication between brain cells is essential for normal brain function. Project Overview Communication between brain cells is essential for normal brain function. Healthy brain cells are controlled through chemical messengers that stimulate or inhibit brain activity. Current theories indicate...
-
Oncolytic rhabdovirus immunotherapy for brain cancer
https://braincanada.ca/fr/subventions-financées/oncolytic-rhabdovirus-immunotherapy-for-brain-cancerDr David Stojdl’s lab has custom‑built an oncolytic virus biotherapy specifically for the treatment of the devastating brain cancer, glioblastoma multiforme (GBM). Project Overview Dr David Stojdl’s lab has custom‑built an oncolytic virus biotherapy specifically for the treatment of the devastating...